Clinical trial Recruiting at 1 site Observational Ages 20 to 80

Using Angio-CT and MRI to Manage Chronic Musculoskeletal Pain

Official title: The Combined Utility of Angio-CT and MRI in Managing Chronic Musculoskeletal Pain: a Prospective Study to Evaluate the Efficacy of Transarterial Microembolization

Run by Tri-Service General Hospital (TSGH) · NCT06509087 · Data updated 2026-11-12

This study is testing a new way to treat chronic musculoskeletal pain using a minimally invasive technique that combines advanced imaging to help patients who haven't found relief with standard treatments.

More Magnetic Resonance Imaging trials

Quick facts

Study typeObservational
Ages20 Years to 80 Years
SexAll
Enrollment60 (estimated)
SponsorTri-Service General Hospital (TSGH)
Academic / other
Locations1 site (Taipei)
StatusRecruiting
StartedJuly 25, 2024
Main results expectedJuly 31, 2025
Study endsJuly 31, 2027
Registry record updatedAugust 28, 2024
Trial IDNCT06509087 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients with chronic shoulder or knee pain due to conditions like degenerative arthritis or tendinopathy who have not benefited from conservative treatments.

Probably not a fit

Patients with pregnancy, coagulation disorders, local infections, tumors, or allergies to contrast agents may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of transarterial microembolization (TAME) for patients suffering from chronic musculoskeletal pain who have not responded to traditional treatments. It integrates preoperative MRI findings with intraoperative imaging from CT and angiography to enhance treatment planning and outcomes. The goal is to provide a more precise and effective approach to managing pain through this minimally invasive technique. By focusing on abnormal blood vessel growth, the study aims to improve the overall success of pain interventions.

Why it matters

Potential benefit: If successful, this approach could significantly reduce chronic pain for patients who have exhausted other treatment options.

How similar studies have gone: While the integration of imaging techniques in pain management is promising, this specific approach using TAME is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with chronic musculoskeletal shoulder or knee joint pain in our hospital, including degenerative knee arthritis, adhesive capsulitis of the shoulder, and those confirmed by physical examination or ultrasound-guided injection to have tendinopathy or ligamentopathy, who have failed drug therapy, rehabilitation, or injection treatments, with a duration of symptoms greater than three months, are the target population of this study.

Exclusion Criteria:

* Pregnancy, coagulation disorders, symptoms of relevant local infections or tumors, and patients allergic to contrast agents. Patients must have complete medical records; those who do not meet the inclusion criteria will be excluded.

Where it's running

  • Tri-Service General Hospital
    Taipei, Taiwan
    Recruiting

Study contacts

  • Principal investigator: Yi-Chih Hsu, M.D. — Tri-Service General Hospital, National Defense Medical Center
  • Study coordinator: Yi-Chih Hsu, M.D.
  • Email: doc31578@gmail.com
  • Phone: +886-2-8792 3311

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.